Patent details

EP2174666 Title: MEDICINAL AGENT FOR TREATMENT OF AMYLOID BETA-INDUCED CEREBRAL CIRCULATION OR CEREBRAL BLOOD FLOW DISORDERS

Basic Information

Publication number:
EP2174666
PCT Application Number:
PCT/JP/2008/060513
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP087653143
PCT Publication Number:
WO/2009/001661
First applicant's nationality:
Translation Language:
EPO Publication Language:
Not available
English Title of Invention:
MEDICINAL AGENT FOR TREATMENT OF AMYLOID BETA-INDUCED CEREBRAL CIRCULATION OR CEREBRAL BLOOD FLOW DISORDERS
French Title of Invention:
AGENT MÉDICAMENTEUX POUR LE TRAITEMENT DE TROUBLES DE LA CIRCULATION CÉRÉBRALE OU DU FLUX SANGUIN CÉRÉBRAL INDUITS PAR L'AMYLOÏDE BÊTA
German Title of Invention:
MEDIZINISCHES MITTEL ZUR BEHANDLUNG VON AMYLOID BETA-INDUZIERTEN STÖRUNGEN DER CEREBRALEN ZIRKULATION ODER DES CEREBRALEN BLUTFLUSSES
SPC Number:

Dates

Filing date:
09/06/2008
Grant date:
18/12/2013
EP Publication Date:
18/12/2013
PCT Publication Date:
31/12/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/04/2010
EP B1 Publication Date:
18/12/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
09/06/2014
Expiration date:
09/06/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/06/2008
 
 

Name:
Daiichi Sankyo Company Limited
Address:
3-5-1, Nihonbashi Honcho, Chuo-ku Tokyo 103-8426, Japan (JP)

Name:
Osaka University
Address:
1-1, Yamadaoka, Suita-shi Osaka 565-0871, Japan (JP)

Inventor

1

Name:
TAKEDA Shuko
Address:
Japan (JP)

2

Name:
MORISHITA Ryuichi
Address:
Japan (JP)

3

Name:
SATO Naoyuki
Address:
Japan (JP)

Priority

Priority Number:
2007165071
Priority Date:
22/06/2007
Priority Country:
Japan (JP)

Classification

Main IPC Class:
A61K 31/41;
Filing date Document type Number of pages